Developing story β details emerging. Check the source link for the latest updates.
Source: [Yahoo Finance](https://finance.yahoo.com/technology/articles/absa-updates-credit-risk-systems-114237927.html)
Developing story β details emerging. Check the source link for the latest updates.
Lillyβs sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.
Developing story β details emerging. Check the source link for the latest updates.